|
|
|
|
|
|
by refurb
594 days ago
|
|
|
> Maybe a shorter duration(<5yrs) patent(for lack of better word) for unapproved generics might do the trick. There already is something similar - the NDA exclusivity period. You get 3-5 years where the FDA won't approve any other versions of the product. https://www.tandfonline.com/doi/pdf/10.4155/ppa.14.30 But ambroxol isn't a decongestant - it supposed to help with phlegm. |
|
|